Discovery of Pyridones As Oral AMPK Direct Activators

AMP-activated protein kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme that is activated in shortage of energy and suppressed in its surfeit. AMPK activation stimulates fatty acid oxidation, enhances insulin sensitivity, alleviates hyperglycemia and hyperlipidemia, and inhibits proin...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2013-07, Vol.4 (7), p.632-636
Main Authors: Mirguet, Olivier, Sautet, Stéphane, Clément, Catherine-Anne, Toum, Jérôme, Donche, Frédéric, Marques, Celine, Rondet, Emilie, Pizzonero, Mathieu, Beaufils, Benjamin, Dudit, Yann, Huet, Pascal, Trottet, Lionel, Grondin, Pascal, Brusq, Jean-Marie, Boursier, Eric, Saintillan, Yannick, Nicodeme, Edwige
Format: Article
Language:English
Subjects:
Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AMP-activated protein kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme that is activated in shortage of energy and suppressed in its surfeit. AMPK activation stimulates fatty acid oxidation, enhances insulin sensitivity, alleviates hyperglycemia and hyperlipidemia, and inhibits proinflammatory changes. Thus, AMPK is a well-received therapeutic target for type 2 diabetes and other metabolic disorders. Here, we will report the discovery of pyrrolopyridone derivatives as AMPK direct activators. We will illustrate the synthesis and structure–activity relationships of the series as well as some pharmacokinetic results. Some compounds exhibited encouraging oral exposure and were evaluated in a mouse diabetic model. Compound 17 showed oral activity at 30 mg/kg on blood glucose.
ISSN:1948-5875
1948-5875
DOI:10.1021/ml400157g